Shattuck Labs (STTK)
(Delayed Data from NSDQ)
$10.35 USD
-0.07 (-0.67%)
Updated May 13, 2024 04:00 PM ET
After-Market: $10.35 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Brokerage Reports
Shattuck Labs, Inc. [STTK]
Reports for Purchase
Showing records 21 - 28 ( 28 total )
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Following a Year of Execution, Three Key Clinical Readouts on the Horizon
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
3Q22 Results; Multiple SL-172154 Readouts on Track During 1H23; GADLEN Update at SITC
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
2Q22 Results; SL-172154 Advances; Phase 1b Study in PROC Expected to Begin Shortly; Multiple Readouts by 1H23
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Magrolimab Green Light From FDA and ASCO Updates Bode Well for SL-172154
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
BMY Engages Gamma Delta T-cells; We Believe This Bolsters GADLEN Visibility
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
1Q22 Results; Bolstered by Strong Cash Position, Lead Assets Continue Rapid Progress in the Clinic
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Shattuck Labs, Inc.
Industry: Medical - Biomedical and Genetics
Modular Therapies Packing a Powerful One-Two Punch; Initiating at Buy and $28 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J